Autoantibodies in childhood opsoclonus-myoclonus syndrome

被引:29
|
作者
Blaes, F. [1 ]
Pike, M. G. [3 ]
Lang, B. [2 ]
机构
[1] Univ Giessen, Dept Neurol, Giessen, Germany
[2] Univ Oxford, Dept Clin Neurol, Oxford, England
[3] John Radcliffe Hosp, Dept Paediat Neurol, Oxford OX3 9DS, England
关键词
Opsoclonus-myoclonus syndrome; Dancing Eye Syndrome; Neuroblastoma; Autoantibodies; Cell proliferation; Case report;
D O I
10.1016/j.jneuroim.2008.05.033
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Opsoclonus-myoclonus syndrome or Dancing Eye Syndrome (OMS/DES) is a rare neurological disorder of children, which associates with neuroblastoma (NB) in approximately 50% of cases. We examined sera from five patients with (OMS-NB+) and five without NB (OMS-NB-) for autoantibodies. OMS-NB- IgG bound to the surface of a NB cell line, whereas IgG from OMS-NB+ and from NB patients Without OMS/DES bound only to permeabilised. cells. Both OMS-NB+ and OMS-NB- reduced proliferation of NB cells. We also present a case report of a child with OMS/DES without NB who made a complete recovery without treatment. Serum antibodies at presentation bound to the surface and decreased NB cell proliferation but had decreased 9 weeks later when the child was asymptomatic. These results demonstrate that sera from some OMS/DES patients contain IgG antibodies that are potentially pathogenic. (c) 2008 Elsevier B.V All rights reserved.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 50 条
  • [41] Opsoclonus-myoclonus paraneoplastic syndrome in nasopharyngeal carcinoma
    Stewart, Kirsten E.
    Zeidler, Martin
    Srinivasan, Devraj
    Yeo, Justin C. L.
    BMJ CASE REPORTS, 2022, 15 (10)
  • [42] SYNDROME OF OPSOCLONUS-MYOCLONUS IN HYPEROSMOLAR NONKETOTIC COMA
    MATSUMURA, K
    SONOH, M
    TAMAOKA, A
    SAKUTA, M
    ANNALS OF NEUROLOGY, 1985, 18 (05) : 623 - 624
  • [43] Opsoclonus-myoclonus in Aicardi-Goutieres syndrome
    Alburaiky, Salam
    Dale, Russell C.
    Crow, Yanick J.
    Jones, Hannah F.
    Wassmer, Evangeline
    Melki, Isabelle
    Boespflug-Tanguy, Odile
    Do Cao, Jeremy
    Gras, Domitille
    Sharpe, Cynthia
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2021, 63 (12): : 1483 - 1486
  • [44] Cyclophosphamide therapy in pediatric Opsoclonus-Myoclonus syndrome
    Pranzatelli, MR
    Tate, ED
    Travelstead, AL
    Grana, N
    Parkhurst, J
    Russell, C
    ANNALS OF NEUROLOGY, 2005, 58 : S90 - S90
  • [45] Opsoclonus-myoclonus syndrome associated with cytomegalovirus encephalitis
    Zaganas, I.
    Prinianakis, G.
    Xirouchaki, N.
    Mavridis, M.
    NEUROLOGY, 2007, 68 (19) : 1636 - 1636
  • [46] Transient opsoclonus-myoclonus syndrome secondary neuroblastoma to
    Koul, Roshan
    Al-Futaisi, Amna
    Williams, Ranjan
    Javad, Hashim
    Chacko, Alexander
    NEUROSCIENCES, 2007, 12 (03) : 253 - 255
  • [47] Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS)
    Krasenbrink, I.
    Fuehlhuber, V.
    Juhasz-Boess, I.
    Stolz, E.
    Hahn, A.
    Kaps, M.
    Hero, B.
    Blaes, F.
    NEUROPEDIATRICS, 2007, 38 (03) : 114 - 116
  • [48] Augmented startle responses in opsoclonus-myoclonus syndrome
    Yonekawa, Takahiro
    Saito, Yoshiaki
    Sakuma, Hiroshi
    Sugai, Kenji
    Shimizu, Yuko
    Inagaki, Masumi
    Sasaki, Masayuki
    BRAIN & DEVELOPMENT, 2011, 33 (04): : 335 - 338
  • [49] Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma
    Gold, Carl A.
    Lassman, Andrew B.
    Odia, Yazmin
    JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (02) : 315 - 316
  • [50] Opsoclonus-myoclonus syndrome secondary to duloxetine poisoning
    Trigo Lopez, J.
    Martinez Pias, E.
    Carrancho Garcia, A.
    Pedraza Hueso, M. I.
    NEUROLOGIA, 2021, 36 (03): : 250 - 252